Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Congratulations to Dr. Michael Fehlings on his appointment as the Robert Campeau Family Foundation/Dr. C.H. Tator Chair in Brain and Spinal Cord Research at UHN.
The award, which was effective Feb. 1, 2022, will facilitate research aimed at improving outcomes for individuals suffering from injuries and diseases impacting the central nervous system. Funds from the award will support his vibrant research program, provide educational opportunities to graduate students in his lab, and enable knowledge translation efforts.
Dr. Fehlings, Senior Scientist at UHN's Krembil Brain Institute and staff neurosurgeon at Toronto Western Hospital, is Vice-Chair of Research, Department of Surgery at the University of Toronto and Co-Director of the U of T Spine Program.
In the fall of 2008, Dr. Fehlings was appointed the inaugural Director of the U of T Neuroscience Program, which he held until June 2012. He combines an active clinical practice in complex spinal surgery with a translationally oriented research program focused on discovering novel treatments to improve functional outcomes following spinal cord injury.
Congratulations to the Cardiac Intensive Care Unit (CICU) team at Toronto General Hospital (members pictured here), and Toronto Western Hospital's Medical Surgical Neuro Intensive Care Unit (MSNICU) team and Respiratory Therapy team. These three teams were recognized with the Trillium Gift of Life's Hidden Heroes Award.
The awards were delivered during National Organ and Tissue Awareness Week (NOTDAW) in the last week of April.
And, congratulations individual winners of the Hidden Heroes Awards:
These individuals and teams are being celebrated for their hard work to support and facilitate organ and tissue donation in UHN intensive care units. Their work help save countless lives through transplantation every year.
Three researchers at UHN's Princess Margaret Cancer Centre (PM), Drs. Fei-Fei Liu, Daniel De Carvalho and John Dick, have been recognized with prestigious honours from the American Association of Cancer Research (AACR), the largest professional organization dedicated to advancing cancer research.
"Drs. Fei-Fei Liu, De Carvalho and Dick have made outstanding contributions to our understanding of cancer initiation and progression," says Dr. Brad Wouters, UHN's Executive Vice-President of Science and Research. "Their insights are changing the treatment landscape for patients.
"These awards and honours recognize the international calibre of these scientists and the impact that they and their research teams are having on the lives of patients."
Dr. Liu has been named Chair-Elect of the AACR Radiation Science Medicine (AACR-RSM) Working Group. Dr. Liu will work with the AACR to guide the direction of radiation research for 2022-2023.
Dr. Liu is a Senior Scientist at PM, Chief of the Radiation Medicine Program at UHN, and Chair of the Department of Radiation Oncology at U of T. She has made many notable contributions to the field of radiation oncology through various roles in research, education and patient care, where her expertise is highly sought after.
"I'm honoured to serve as the Chair of the AACR Radiation Science Medicine Working Group," said Dr. Liu "It is a great privilege, and I'm excited to contribute to advancing the organization's overarching goal to prevent and cure cancer with a focus on advancing the field of radiation oncology. It's inspiring to join a network of dedicated experts who share a strong drive to promote research, collaboration and education. These efforts are vital to paving the way for new therapies, fostering future leaders in radiation medicine research, and ultimately improving health the lives of patients and their families."
Dr. Daniel De Carvalho has been awarded the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award honours Dr. De Carvalho's research into developing a highly sensitive and accurate blood test for cancer detection and characterization. It also recognizes his discovery of "viral mimicry" – a process that can be used to wake up the immune system so that it targets cancer cells. The process involves activating the production of double-stranded RNA (dsRNA) in cancer cells. The dsRNA molecule is typically found in viruses and is a "red flag" that notifies the immune system of an infection. By producing dsRNA in cancer cells, the process mimics an infection and instructs the body to initiate an anticancer immune response.
The award was established to celebrate the achievements of the late Dr. Waun Ki Hong, whose research advanced the field of targeted cancer therapy. It recognizes early- and mid-career scientists for their extraordinary contributions to cancer research.
"I am extraordinarily honoured to receive the 2022 AACR-Waun Ki Hong Award, acknowledging the significance of my research to the fields of cancer early detection and therapeutic development," said Dr. De Carvalho. "Blood-based detection of cancer in early stages when treatment can be more effective could have a profound impact on patient outcomes. Tricking cancer cells to behave as a virus-infected cell, a process we described as viral mimicry, has the potential to unleash a strong immune response against the tumor."
Dr. De Carvalho is a Senior Scientist at PM, an Associate Professor in the Department of Medical Biophysics at U of T, and scientific co-founder of Adela. His pioneering research, which mixes epigenetic analyses and machine learning, has led to earlier detection of cancer and opened new avenues for cancer therapies.
Dr. John Dick is the inaugural recipient of the AACR Award for Outstanding Achievement in Blood Cancer Research. The award honours Dr. Dick's discovery of leukemia stem cells, as well as his work on characterizing the mechanisms by which these cells contribute to normal and leukemic hematopoiesis. Dr. Dick is also recognized for developing the first hematopoietic xenograft assay – an experimental technique for generating distinct classes of blood cells from stem cells. This technique has allowed his team to develop models of human acute lymphoid leukemia, acute myeloid leukemia and chronic myeloid leukemia that have provided important insights into these diseases.
Dr. Dick is a Senior Scientist at PM, a Professor in the Department of Molecular Genetics at U of T, and a Tier 1 Canada Research Chair in Stem Cell Biology. His discoveries have provided actionable targets for drug development, improved approaches to preventing cancer relapse and led to the development of tools to predict cancer survival and treatment outcomes.
"I am incredibly honored to receive the AACR Award for Outstanding Achievement in Blood Cancer Research," said Dr. Dick. "Science is not done in isolation and I have had the good fortune to be surrounded by wonderful colleagues in Toronto who continuously challenged me to tackle biological challenges with rigour and clear thinking. I dedicate this award to them and all the students and post-docs who contributed so much to the thinking and execution of the experimental findings."
Congratulations to Drs. Liu, De Carvalho and Dick.